| scholarly article | Q13442814 |
| P2093 | author name string | K. Ozawa | |
| Y. Matsumoto | |||
| T. Suzuki | |||
| T. Tobe | |||
| I. Honjo | |||
| I. Asada | |||
| P2860 | cites work | A staging system for hepatocellular carcinoma: Prognostic factors in Ugandan patients | Q38893845 |
| Serum alpha-fetoprotein in 184 Ugandan patients with hepatocellular carcinoma. Clinical, laboratory, and histopathologic correlations | Q38894302 | ||
| Effect of surgical and chemotherapeutic treatment on alpha-fetoprotein levels in patients with hepatocellular carcinoma | Q39370947 | ||
| Alpha-fetoprotein in ontogenesis and its association with malignant tumors | Q39866720 | ||
| Alpha-fetoprotein and germ cell tumors: a possible role of yolk sac tumor in production of alpha-fetoprotein. | Q53811264 | ||
| Immunofluorescent study of alpha-foetoprotein (alpha-fp) in liver and liver liver tumours. I. Technique of alpha-fp localization in tissue sections. | Q53896028 | ||
| Response of alpha-fetoprotein to chemotherapy in patients with hepatomas | Q70025902 | ||
| Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies | Q73490475 | ||
| Production of embryonal alpha-globulin by transplantable mouse hepatomas | Q76429313 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | oncology | Q162555 |
| hepatocellular carcinoma | Q1148337 | ||
| P304 | page(s) | 354-360 | |
| P577 | publication date | 1982-01-01 | |
| 1982-01-15 | |||
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Clinical classification of hepatoma in Japan according to serial changes in serum alpha-fetoprotein levels | |
| P478 | volume | 49 |
| Q34611637 | A multi-institutional phase II study of the efficacy and tolerability of lapatinib in patients with advanced hepatocellular carcinomas |
| Q36125576 | Analysis of the risk factors for early death due to disease recurrence or progression within 1 year after hepatectomy in patients with hepatocellular carcinoma |
| Q36397382 | Antihepatoma effect of alpha-fetoprotein antisense phosphorothioate oligodeoxyribonucleotides in vitro and in mice |
| Q36648618 | Chemistry and Biology of α-Fetoprotein |
| Q69083939 | Chemotherapy of a patient because of spuriously elevated alpha-fetoprotein levels. Identification of the responsible factor |
| Q69333960 | Clinicopathological features of malignancy in hepatocellular carcinoma |
| Q39648514 | Combined measurement of preoperative α-fetoprotein and des-γ-carboxy prothrombin predicts recurrence after curative resection in patients with hepatitis-B-related hepatocellular carcinoma. |
| Q91916819 | Daily decrease of post-operative alpha-fetoprotein by 9% discriminates prognosis of HCC: A multicenter retrospective study |
| Q40353838 | Downregulation of alpha-fetoprotein siRNA inhibits proliferation of SMMC-7721 cells |
| Q57696098 | Hepatocellular carcinoma |
| Q44868875 | Hepatocellular carcinoma specific graded prognostic assessment can predict outcomes for patients with brain metastases from hepatocellular carcinoma |
| Q34549268 | Identification of novel serum biomarkers of hepatocellular carcinoma using glycomic analysis |
| Q39528390 | MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma. |
| Q47578368 | Multiplication of alpha-fetoprotein and protein induced by vitamin K absence-II is a powerful predictor of prognosis and recurrence in hepatocellular carcinoma patients after a hepatectomy |
| Q67518277 | Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival |
| Q43502398 | Paraneoplastic syndromes in patients with hepatocellular carcinoma in Taiwan |
| Q42793211 | Postoperative changes in protein-induced vitamin K absence or antagonist II levels after hepatectomy in patients with hepatocellular carcinoma: relationship to prognosis |
| Q38168123 | Present status of serum tumor markers in diagnosis, prognosis, and evaluation of therapy |
| Q40105618 | Primary carcinoma of the liver: Diagnosis, prognosis, and management |
| Q41729061 | Primary hepatic malignant neoplasms |
| Q34446810 | Prognosis of patients with hepatocellular carcinoma. Validation and ranking of established staging-systems in a large western HCC-cohort |
| Q37575639 | Role of alpha-fetoprotein in hepatocellular carcinoma: prognostication, treatment monitoring or both? |
| Q44520387 | Serum alpha-L-fucosidase. A more sensitive marker for hepatocellular carcinoma? |
| Q34760780 | Spectrum of hepatocellular carcinoma on triple phase helical CT: a pictorial essay |
| Q93510578 | Spontaneous regression of hepatocellular carcinoma |
| Q52582281 | Ultrasonography and alpha-fetoprotein in diagnosis of hepatocellular carcinoma in cirrhosis. |
Search more.